EUVIMEDEUVIMED entdecken
Crossref

Assessing the Efficacy and Safety of Dapagliflozin and Empgliflozin as an Add-on Therapy for Lowering Glycated Hemoglobin and Weight in Type-2 Diabetes Mellitus Patients

Mahima Makhija, Alka Bansal, Lokendra Sharma, Punam Jakhar, Susheel Kumar, Ashish Agrawal

RUHS Journal of Health Science · 2025

DOI: 10.37821/ruhsjhs.10.2.2025.783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift RUHS Journal of Health Science, 2025. Verfasst von Mahima Makhija und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Makhija, M., Bansal, A., Sharma, L., Jakhar, P., Kumar, S., & Agrawal, A. (2025). Assessing the Efficacy and Safety of Dapagliflozin and Empgliflozin as an Add-on Therapy for Lowering Glycated Hemoglobin and Weight in Type-2 Diabetes Mellitus Patients. RUHS Journal of Health Science. https://doi.org/10.37821/ruhsjhs.10.2.2025.783

Vancouver

Makhija M, Bansal A, Sharma L, Jakhar P, Kumar S, Agrawal A. Assessing the Efficacy and Safety of Dapagliflozin and Empgliflozin as an Add-on Therapy for Lowering Glycated Hemoglobin and Weight in Type-2 Diabetes Mellitus Patients. RUHS Journal of Health Science. 2025. doi:10.37821/ruhsjhs.10.2.2025.783

BibTeX
@article{Makhija2025,
  author = {Makhija, Mahima and Bansal, Alka and Sharma, Lokendra and Jakhar, Punam and Kumar, Susheel and Agrawal, Ashish},
  title = {Assessing the Efficacy and Safety of Dapagliflozin and Empgliflozin as an Add-on Therapy for Lowering Glycated Hemoglobin and Weight in Type-2 Diabetes Mellitus Patients},
  journal = {RUHS Journal of Health Science},
  year = {2025},
  doi = {10.37821/ruhsjhs.10.2.2025.783}
}
Kostenlos starten →